When comparing 47 published breast cancer outcome signatures to random gene signatures of identical size, 60% of published signatures were not significantly better at predicting outcome and 23% were worse predictors than the median random signature. This indicates that the predictive power of many published cancer signatures does not exceed what would be expected from random gene selection. [@venet_most_2011]